rheumatic disease: Inflammatory and degenerative diseases of connective tissue structures, such as arthritis.
| Name | RHEUMA_ENDPOINTS |
|---|---|
| Long name | Finngen Rheumatological endpoints |
| Include | RHEUMA_ARHTROPAT_REACTIVE, RHEUMA_SEROPOS, RHEUMA_SERONEG, JUVEN_ARTHR, PSOR_ENTE_ARTHR, GOUT, RHEUMA_CHRYSTAL, ARTHRO_SPEC, RHEU_ARTHRITIS_OTH, COX_ARTHROSIS, KNEE_ARTHROSIS, SLE_FG, NECROVASC_FG, DERMATOPOLY_FG, SYSTSCLE_FG, OTHER_SYSTCON_FG, SYSTINOTH_FG, SPONDYLOPATHY_FG, M13_FIBROMYALGIA, OSTEOPOROSIS_FRACTURE_FG |
| First defined in version | DF2 |
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 45958 | 27039 | 18919 |
| Unadjusted prevalence (%) | 21.18 | 22.01 | 20.10 |
| Mean age at first event (years) | 55.53 | 54.84 | 56.52 |
| Case fatality at 5-years (%) | 2.28 | 1.58 | 3.29 |
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 3.0 | 3.0 | 3.0 |
| Recurrence at 6 months (%) | 59.74 | 62.67 | 55.56 |
before Finngen Rheumatological endpoints
after Finngen Rheumatological endpoints
Loading survival analyses plot…
Loading survival analyses table…